Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety and Efficacy of iDose® TR With Cataract Surgery vs. Cataract Surgery Alone
Sponsor: Glaukos Corporation
Summary
This trial will evaluate the safety and IOP -lowering efficacy of administering an iDose TR (travoprost intracameral implant) in conjunction with cataract surgery compared to cataract surgery alone
Official title: Multicenter, Randomized, Double-masked, Parallel Group Trial to Evaluate the Safety and Efficacy of iDose® TR (Travoprost Intracameral Implant) in Conjunction With Cataract Surgery vs. Cataract Surgery Alone
Key Details
Gender
All
Age Range
45 Years - Any
Study Type
INTERVENTIONAL
Enrollment
132
Start Date
2025-01-13
Completion Date
2027-06
Last Updated
2026-01-21
Healthy Volunteers
No
Interventions
iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery
iDose TR (travoprost intracameral implant) 75 µg in conjunction with cataract surgery
Sham procedure in conjunction with cataract surgery
Sham procedure in conjunction with cataract surgery
Locations (1)
Glaukos Investigator Site
Kenosha, Wisconsin, United States